Skip to content
Studies have shown that active fund managers routinely underperform the S&P500 index*
Home
Articles
WALL STREET X
Forecasts
Portfolios
Wall Street X
Articles
Forecasts
Portfolios
Search
Results for
{phrase}
(
{results_count}
of
{results_count_total}
)
Displaying
{results_count}
results of
{results_count_total}
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN)
REGN Stock Predictions and Ratings
WSX Rating:
STRONG BUY
WSX Forecast (1yr):
26%
Analyst Rating:
BUY
Analyst Forecast (1yr):
28.80%
REGN Stock Analysis
REGN
PE Ratio:
15.1
REGN
PEG Ratio:
0.8
REGN
Forward EPS Growth (12 month):
19.00%
REGN
PS Ratio:
4.3
REGN
PSG Ratio:
0.4
REGN
Forward Revenue Growth (12 month):
11.00%
REGN Articles
No data was found